当前位置: 首页 > 医疗版 > 症状 > P > 疲乏
编号:13540436
基于症状群管理方案对肺癌化疗患者疲乏及睡眠质量的影响(1)
http://www.100md.com 2019年8月1日 《世界睡眠医学杂志》 20198
     摘要 目的:探讨基于症状群管理方案对肺癌化疗患者疲乏及睡眠质量的影响。方法:选取2017年1月至2019年1月广安市人民医院收治的肺癌化疗患者82例作为研究对象,随机将患者分为2组,每组41例,对照组实施常规护理干预,观察组在常规护理干预基础上使用症状群管理方案,观察分析2组干预前,干预3周疲乏、睡眠质量、疼痛程度、生命质量情况。结果:干预前,2组疲乏量表(RPFS)、简明疼痛评估量表(BPI)、匹茨堡睡眠质量指数量表(PSQI)评分无统计学意义(P>0.05),干预3周,观察组RPFS、BPI、PSQI评分均显著低于对照组(P<0.05);干预前,2组生命质量核心量表(EORTC QOQ-C30)各项评分无统计学意义(P>0.05),干预3周,观察组功能量表和总体健康量表评分显著高于对照组,而症状量表和单一症状量表评分显著低于对照组(P<0.05)。结论:基于症状群管理方案可显著改善肺癌化疗患者疲乏症状,提高睡眠质量及生命质量。

    关键词 症状群管理方案;肺癌;疲乏;睡眠质量

    Abstract Objective:To investigate the effect of symptom group-based management on fatigue and sleep quality in patients with lung cancer undergoing chemotherapy.Methods:The study included between January 2017 and January 2019,82 cases of lung cancer chemotherapy patients as the research object,randomly divided the patients into two groups,each group of 41 cases,control group routine nursing intervention,the observation group on the basis of conventional nursing intervention using symptom group management plan,analyze the two groups before intervention,intervention 3 weeks fatigue,sleep quality,pain degree,the quality of life.Results:Before intervention,there was no significant difference in RPFS,BPI and PSQI scores between the two groups (P>0.05).After 3 weeks of intervention,RPFS,BPI and PSQI scores in the observation group were significantly lower than those in the control group (P<0.05).Before the intervention,there was no significant difference in the scores of EORTC qoq-c30 (EORTC qoq-c30) between the two groups (P>0.05).After 3 weeks of intervention,the scores of functional scale and overall health scale in the observation group were significantly higher than those in the control group,while the scores of symptom scale and single symptom scale were significantly lower than those in the control group (P<0.05).Conclusion:Symptom-based management scheme can significantly improve fatigue symptoms,sleep quality and life quality in patients with lung cancer undergoing chemotherapy.

    Key Words Symptom group management scheme;Lung cancer;The weary;The quality of sleep

    中圖分类号:R338.63文献标识码:Adoi:10.3969/j.issn.2095-7130.2019.01.002

    肺癌是对人群健康及生命威胁最大的恶性肿瘤之一,其发病率和死亡率居恶性肿瘤之首。化疗是治疗肺癌的主要手段之一,可杀伤肿瘤细胞,延长生存期,但易引起恶心、脱发、食欲减退、疲乏、失眠等不良反应,严重降低其生命质量。相关研究表明[1],50%以上肺癌患者同时存在疲乏,睡眠障碍及疼痛的集群现象,严重影响预后。常规护理干预在改善患者疲乏症状,提高睡眠质量方面作用有限,本研究将基于症状群管理方案应用于临床,取得较好效果,报道如下。

    1 资料与方法

    1.1 一般资料

    选取2017年1月至2019年1月广安市人民医院收治的肺癌化疗患者82例作为研究对象,随机将患者分为2组,每组41例,观察组中男24例,女17例;年龄34~64岁,平均年龄(45.15±4.34)岁;病理类型:鳞癌13例,腺癌19例,其他9例;TNM分期:II期8例,III期16例,IV期17例。对照组中男26例,女15例;年龄33~66岁,平均年龄(45.24±4.39)岁;病理类型:鳞癌12例,腺癌21例,其他8例;TNM分期:II期9例,III期14例,IV期18例。2组患者一般资料经统计学分析,差异无统计学意义(P>0.05),具有可比性。, http://www.100md.com(应伟 李程 江波 王兴远 周伟)
1 2下一页


    参见:首页 > 医疗版 > 症状 > P > 疲乏